Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial
المؤلفون المشاركون
Zhao, Shuai
Tang, Yong
Cai, Hairong
Liu, Weifeng
Zhang, Lieyuan
Chen, Dongjie
Chen, Bojun
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-9، 9ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-03-07
دولة النشر
مصر
عدد الصفحات
9
التخصصات الرئيسية
الملخص EN
Objective.
This double-blind and randomized placebo-controlled trial evaluated the safety and efficacy of Danhong injection combined with Naoxintong capsule in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI).
Methods.
ACS patients scheduled to undergo PCI (n=130) were equally and randomly apportioned to either a treatment or control group.
After PCI, the treatment group received Danhong injection combined with Naoxintong capsule for 12 weeks, while the control group was given placebo.
Both groups were otherwise treated with conventional secondary prevention of coronary artery disease.
The groups were primarily evaluated for clinical efficacy and cardiovascular events.
Evaluative indicators of safety included adverse events, platelet count, and liver, renal, and blood coagulation functions.
Result.
No cardiovascular events or adverse reactions were observed in either group.
The treatment group demonstrated better signs of clinical efficacy, including left ventricular ejection fraction, higher nitric oxide levels, and lower levels of endothelin-1 (ET-1) and von Willebrand factor (VWF).
Conclusion.
ACS patients treated with Danhong injection combined with Naoxintong capsule after PCI demonstrated better improvement with regard to markers associated with atherosclerosis and adverse cardiovascular events, without apparent adverse effects.
Thus, Danhong injection combined with Naoxintong capsule was safe and effective for treating ACS patients after PCI.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Zhao, Shuai& Tang, Yong& Cai, Hairong& Liu, Weifeng& Zhang, Lieyuan& Chen, Dongjie…[et al.]. 2018. Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial. Evidence-Based Complementary and Alternative Medicine،Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1156578
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Zhao, Shuai…[et al.]. Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial. Evidence-Based Complementary and Alternative Medicine No. 2018 (2018), pp.1-9.
https://search.emarefa.net/detail/BIM-1156578
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Zhao, Shuai& Tang, Yong& Cai, Hairong& Liu, Weifeng& Zhang, Lieyuan& Chen, Dongjie…[et al.]. Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial. Evidence-Based Complementary and Alternative Medicine. 2018. Vol. 2018, no. 2018, pp.1-9.
https://search.emarefa.net/detail/BIM-1156578
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1156578
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر